Cargando…

Development of a Potent and Protective Germline-Like Antibody Lineage Against Zika Virus in a Convalescent Human

Zika virus (ZIKV) specific neutralizing antibodies hold great promise for antibody-based interventions and vaccine design against ZIKV infection. However, their development in infected patients remains unclear. Here, we applied next-generation sequencing (NGS) to probe the dynamic development of a p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Fei, Lin, Xiaohe, He, Linling, Wang, Ruoke, Wang, Han, Shi, Xuanling, Zhang, Fuchun, Yin, Chibiao, Zhang, Linqi, Zhu, Jiang, Yu, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821881/ https://www.ncbi.nlm.nih.gov/pubmed/31708914 http://dx.doi.org/10.3389/fimmu.2019.02424

Ejemplares similares

A Single Injection of Human Neutralizing Antibody Protects against Zika Virus Infection and Microcephaly in Developing Mouse Embryos
por: Li, Cui, et al.
Publicado: (2018)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
por: Wang, Ruoke, et al.
Publicado: (2022)

Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients
por: Fahad, Ahmed S., et al.
Publicado: (2021)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer
por: He, Linling, et al.
Publicado: (2017)

Disruption of glial cell development by Zika virus contributes to severe microcephalic newborn mice
por: Li, Cui, et al.
Publicado: (2018)

Both structure and function of human monoclonal antibodies contribute to enhancement of Zika virus infectivity in vitro
por: Li, Min, et al.
Publicado: (2017)

Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy
por: Zhu, Xiaoyi, et al.
Publicado: (2021)

Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
por: Cao, Yunlong, et al.
Publicado: (2022)

Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection
por: Zuo, Teng, et al.
Publicado: (2015)

Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses
por: Peng, Yuan, et al.
Publicado: (2022)

Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
por: Ji, Yun, et al.
Publicado: (2022)

Erratum: Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection
por: Zuo, Teng, et al.
Publicado: (2016)

Evolution of Two Major Zika Virus Lineages: Implications for Pathology, Immune Response, and Vaccine Development
por: Beaver, Jacob T., et al.
Publicado: (2018)

Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
por: Zhang, Qi, et al.
Publicado: (2021)

Antibodies and vaccines against Middle East respiratory syndrome coronavirus
por: Xu, Jiuyang, et al.
Publicado: (2019)

Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
por: Wu, Yanling, et al.
Publicado: (2017)

Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model
por: Niu, Xuefeng, et al.
Publicado: (2019)

T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
por: Campe, Julia, et al.
Publicado: (2022)

Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection
por: Khandia, Rekha, et al.
Publicado: (2018)

Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection
por: Li, Mingxi, et al.
Publicado: (2021)

Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
por: Ying, Tianlei, et al.
Publicado: (2015)

Potent and Persistent Antibody Response in COVID-19 Recovered Patients
por: Tian, Xiaodong, et al.
Publicado: (2021)

Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence
por: Fuentes-Villalobos, Francisco, et al.
Publicado: (2022)

Editorial: Updates on convalescent plasma and monoclonal antibody therapies for infectious disease in patients with primary immunodeficiency
por: Condino-Neto, Antonio, et al.
Publicado: (2022)

Neutralization mechanism of a highly potent antibody against Zika virus
por: Zhang, Shuijun, et al.
Publicado: (2016)

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
por: Andreano, Emanuele, et al.
Publicado: (2021)

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021)

Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
por: Xiang, Tiandan, et al.
Publicado: (2021)

A Streamlined Approach to Antibody Novel Germline Allele Prediction and Validation
por: Wendel, Ben S., et al.
Publicado: (2017)

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
por: Steiner, Sophie, et al.
Publicado: (2021)

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Ge, Jiwan, et al.
Publicado: (2021)

Persistence of Zika virus in conjunctival fluid of convalescence patients
por: Tan, Jeslin J. L., et al.
Publicado: (2017)

Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
por: Yan, Renhong, et al.
Publicado: (2021)

Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
por: Dai, Shiyu, et al.
Publicado: (2018)

Self-Assembling Nanovaccine Confers Complete Protection Against Zika Virus Without Causing Antibody-Dependent Enhancement
por: Rong, Heng, et al.
Publicado: (2022)

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
por: Dussupt, Vincent, et al.
Publicado: (2020)

A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
por: Zhu, Qian-Ying, et al.
Publicado: (2021)

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
por: Yang, Zheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hvab48l3t24m4jsve3cvp2743j